Piramal Pharma Limited (NSE:PPLPHARMA)
India · Delayed Price · Currency is INR 150.82
+2.03 (1.36%)
Apr 21, 2026, 3:20 PM IST
Piramal Pharma Market Cap
Piramal Pharma has a market cap or net worth of 197.57 billion as of April 21, 2026. Its market cap has decreased by -31.95% in one year.
Market Cap
197.57B
Enterprise Value
238.64B
Revenue
88.71B
Ranking
n/a
PE Ratio
n/a
Stock Price
150.82
Market Cap Chart
Since October 19, 2022, Piramal Pharma's market cap has decreased from 226.73B to 197.57B, a decrease of -12.86%. That is a compound annual growth rate of -3.85%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Apr 20, 2026 | 197.57B | -13.60% |
| Dec 31, 2025 | 228.67B | -35.22% |
| Dec 31, 2024 | 352.98B | 92.16% |
| Dec 29, 2023 | 183.69B | 34.26% |
| Dec 30, 2022 | 136.81B | -39.66% |
| Oct 19, 2022 | 226.73B | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Ipca Laboratories | 372.59B |
| Ajanta Pharma | 348.46B |
| Emcure Pharmaceuticals | 317.01B |
| Gland Pharma | 296.13B |
| Wockhardt | 228.06B |
| NATCO Pharma | 200.55B |
| Eris Lifesciences | 198.45B |
| Alembic Pharmaceuticals | 148.90B |